Call for evidence- Access to Medicines in the Developing World
APPG enquiry: Achieving Universal Access – The Treatment Timebomb Part II
Deadline for Submissions is Wednesday 19th March 2014, 9am
Background to the Inquiry
In 2009 the All Party Parliamentary Group on HIV and AIDS conducted an inquiry on the supply of affordable anti-retroviral medicines (ARVS), which concluded that the high price of second and third line drugs for HIV was a major barrier to access to HIV treatment. The report was successful in mobilising political support for the Medicines Patent Pool, and in highlighting the “Treatment time bomb” which exists as people in developing countries switch from first line HIV treatment to more expensive second and third line drugs.